Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in programming antibody fragments to crystallize

A B Edmundson1, C A Borrebaeck

  • 1Oklahoma Medical Research Foundation, Oklahoma City 73104, USA.

Immunotechnology : an International Journal of Immunological Engineering
|April 8, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection and characterization of a lectin from non-seed tissue ofPhaseolus vulgaris.

Planta·2013
Same author

Evidence for structurally conserved recognition of the major carbohydrate xenoantigen by natural antibodies.

Cellular and molecular biology (Noisy-le-Grand, France)·2003
Same author

Recognition of IgG-derived peptides by a human IgM with an unusual combining site.

Scandinavian journal of immunology·2002
Same author

Incorporation of long CDR3s into V domains: implications for the structural evolution of the antibody-combining site.

Experimental and clinical immunogenetics·2002
Same author

Human therapeutic antibodies.

Current opinion in pharmacology·2001
Same author

CD40 employs p38 MAP kinase in IgE isotype switching.

Biochemical and biophysical research communications·2001
Same journal

Complementarity-determining region (CDR) implantation: a theme of recombination.

Immunotechnology : an international journal of immunological engineering·1999
Same journal

Recombinant antibodies with the antigen-specific, MHC restricted specificity of T cells: novel reagents for basic and clinical investigations and immunotherapy.

Immunotechnology : an international journal of immunological engineering·1999
Same journal

Sequence-specific antibodies against human IgE isoforms induced by an epitope display system.

Immunotechnology : an international journal of immunological engineering·1999
Same journal

Properties and pharmacokinetics of two humanized antibodies specific for L-selectin.

Immunotechnology : an international journal of immunological engineering·1999
Same journal

An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G protein.

Immunotechnology : an international journal of immunological engineering·1999
Same journal

An scFv phage clone that binds to human beta2-microglobulin.

Immunotechnology : an international journal of immunological engineering·1999
See all related articles

Crystal packing of antibody fragments reveals structural differences between lambda and kappa light chains. These findings inform the design of synthetic antibodies with enhanced crystallization properties.

Area of Science:

  • Immunology
  • Structural Biology
  • Biochemistry

Background:

  • The crystal structure of human B7-15A2 Fab fragment revealed intermolecular antiparallel beta-pleated sheet formation.
  • This packing motif resembles that observed in human Bence-Jones (lambda chain) dimers.
  • The C domains of lambda and gamma 1 chains facilitate these cross-molecule beta-structures.

Purpose of the Study:

  • To investigate the structural basis for crystal packing in antibody fragments.
  • To compare the crystallization propensity of different antibody chain types (lambda vs. kappa).
  • To identify design principles for engineering synthetic antibodies with improved crystallization properties.

Main Methods:

  • X-ray crystallography of human B7-15A2 Fab fragment.

Related Experiment Videos

  • Reexamination of crystal packing interactions in various systems.
  • Structural analysis of C domains (CL and CH1) and VL domains.

    • Main Results:

    • Lambda and gamma 1 CL/CH1 domains form antiparallel beta-structures with neighboring molecules.
    • Kappa CL domains lack this capability due to a proline residue disrupting beta-strand 3-3.
    • VL domains are structurally suited for analogous packing interactions.

    Conclusions:

    • The C domains of lambda and gamma 1 chains, but not kappa chains, support specific intermolecular beta-sheet formation.
    • The VL domains of Fv fragments are also amenable to similar packing interactions.
    • These insights can guide the design of synthetic antibody formats (Fabs, Fvs, single-chain antibodies) with predictable crystallization behavior.